Bladder cancer biomarkers: current approaches and future directions

Bladder cancer biomarkers: current approaches and future directions

Bladder cancer is a significant health concern worldwide, necessitating effective diagnostic and monitoring strategies. Biomarkers play a crucial role in the early detection, prognosis, and treatment of this disease. This review explores the current landscape of bladder cancer biomarkers, including...

Full description

Saved in:

Bibliographic Details
Main Authors:	Melika Ahangar, Frouzandeh Mahjoubi, Seyed Javad Mowla
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-11-01
Series:	Frontiers in Oncology
Subjects:	biomarkers diagnostic strategies prognosis strategies monitoring strategies FDA approved molecular biomarkers
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1453278/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Ferroptosis and its role in osteoarthritis: mechanisms, biomarkers, and therapeutic perspectives
by: Shanyu Lu, et al.
Published: (2024-12-01)

A review of new drugs approved by the food and drug administration in 2022
by: Arjun Swaminathan, et al.
Published: (2023-10-01)

Current biomarkers of prostate cancer
by: I. A. Aboian, et al.
Published: (2021-12-01)

TUBA1B as a novel prognostic biomarker correlated with immunosuppressive tumor microenvironment and immunotherapy response
by: Juntao Qi, et al.
Published: (2025-02-01)

Role of biomarkers in diagnostics, stratification of risk and prognosis of heart failure.
by: О. О. Khanyukov, et al.
Published: (2018-05-01)

Current state of prostate cancer treatment and future strategies
by: Yeonhee Pyo, et al.
Published: (2024-11-01)

FBXW7 in gastrointestinal cancers: from molecular mechanisms to therapeutic prospects
by: Wanqing Wang, et al.
Published: (2024-12-01)

Tackling ALT-positive neuroblastoma: is it time to redefine risk classification systems? A systematic review with IPD meta-analysis
by: Marta Avinent-Pérez, et al.
Published: (2025-02-01)

A year in review: new treatments and expanded indications in dermatology in 2024
by: Lauren N. McGrath, et al.
Published: (2025-12-01)

Semisynthesis: Bridging natural products and novel anticancer therapies
by: Bharat Goel, et al.
Published: (2024-12-01)

Immune responses in rodent whole eye transplantation: elucidation and preliminary investigations into rejection diagnosis and monitoring
by: Bing Li, et al.
Published: (2025-01-01)

Biomarkers for immunotherapy resistance in non-small cell lung cancer
by: Catriona Rother, et al.
Published: (2024-12-01)

A Computational Study of Efficient Combinations of FDA-Approved Drugs and Dietary Supplements in Endometrial Cancer
by: Madhurima Mondal, et al.
Published: (2024-01-01)

A comprehensive overview of selective and novel fibroblast growth factor receptor inhibitors as a potential anticancer modality
by: Jain Nem Kumar, et al.
Published: (2024-03-01)

Exploring emerging concepts of exosomes for the diagnosis, prognosis, and therapeutics of brain cancers
by: Subhrajyoti Banerjee, et al.
Published: (2024-06-01)

Advancements in noninvasive techniques for transplant rejection: from biomarker detection to molecular imaging
by: Yuan Song, et al.
Published: (2025-02-01)

FDA approves leniolisib (Joenja) as the first treatment for APDS: A breaththrough in the field of immunology
by: Muhammad Talha, et al.
Published: (2024-01-01)

Nebivolol, an FDA-Approved Drug, Has General Antibacterial and Antibiofilm Effects and Increases <i>Pseudomonas aeruginosa</i> Tolerance to Ciprofloxacin
by: Yael Schlichter Kadosh, et al.
Published: (2024-11-01)

Tarlatamab and the Future of Immunotherapy: A New Approach to Small Cell Lung Cancer
by: Raza Ur Rehman, MBBS, et al.
Published: (2025-01-01)

Salivary biomarkers: A promising avenue for advancing oral cancer detection
by: Yuvashree Chandrasekaran, et al.
Published: (2024-06-01)

Diagnostics and Therapy for Malignant Tumors
by: Chung-Che Tsai, et al.
Published: (2024-11-01)

Platform Technology in Global Vaccine Regulation: Development, Applications, and Regulatory Strategies with Insights from China
by: Xiaojing Li, et al.
Published: (2024-12-01)

Advances in small extracellular vesicles: roles in the tumor microenvironment and epithelial ovarian cancer diagnosis and treatment
by: Liang Peng, et al.
Published: (2025-02-01)

Etude diagnostique participative du volontariat de développement : Réflexion pour la mise en place d’une stratégie nationale de la promotion du volontariat au Niger
by: Ibrahim MALAM MAMANE SANI, et al.
Published: (2024-05-01)

CENPE is a diagnostic and prognostic biomarker for cervical cancer
by: Peiqiang Peng, et al.
Published: (2024-12-01)

Blood biomarkers for traumatic brain injury: A narrative review of current evidence
by: Iftakher Hossain, et al.
Published: (2024-01-01)

The value of biomarkers in the diagnosis and prognostic analysis of IgA nephropathy
by: Lu Min, et al.
Published: (2025-01-01)

BIRC5 as a prognostic and diagnostic biomarker in pan-cancer: an integrated analysis of expression, immune subtypes, and functional networks
by: Guoyu Li, et al.
Published: (2024-12-01)

Blood biomarkers of hepatocellular carcinoma: a critical review
by: Junsheng Zhao, et al.
Published: (2024-11-01)

Advancement in biomarker of neonatal sepsis
by: QIANG Yuehua, et al.
Published: (2024-11-01)

Tissue Biomarkers in Gastric Cancer Treatment: Present and Future
by: Giulia Airò, et al.
Published: (2024-11-01)

Common diagnostic biomarkers and molecular mechanisms of Helicobacter pylori infection and inflammatory bowel disease
by: Minglin Zhang, et al.
Published: (2024-12-01)

Diagnostic Potential of Cytokine Biomarkers in Endometriosis: Challenges and Insights
by: Laura Krygere, et al.
Published: (2024-12-01)

Predictive biomarkers in daily anatomic pathology – is there something ready for sarcomas? A review and insights for future directions
by: Luiza Fadul Gallas, et al.
Published: (2024-11-01)

DIFFICULTIES OF DIAGNOSTICS AND CHOICE OF SURGICAL APPROACH IN PATIENTS WITH DUCTAL CHOLANGIOCARCINOMA
by: D. A. Granov, et al.
Published: (2017-02-01)

CHOICE OF TREATMENT MANAGEMENT OF ACUTE PANCREATITIS IN RELATION TO PROGNOSIS OF DISEASE COURSE
by: S. V. Avakimyan, et al.
Published: (2016-02-01)

Identification of Contactin-1 as a Potential Biomarker and Therapeutic Target in Neuroblastoma
by: Christa N. Grant, et al.
Published: (2024-11-01)

HEG1 as a novel potential biomarker for the prognosis of lung adenocarcinoma
by: Xin Zou, et al.
Published: (2023-02-01)

tRNA-derived small RNAs: their role in the mechanisms, biomarkers, and therapeutic strategies of colorectal cancer
by: Bo Zhang, et al.
Published: (2025-01-01)

Preoperative evaluation of red blood cell distribution width as a promising biomarker for discriminating between benign and malignant breast tumors and assessing breast cancer activity
by: Ajay Singh Thakur, et al.
Published: (2024-04-01)